Showing results (251-260 of 1,282) with videos related to

Sort By:
Pageof 129
Cardiovascular Diabetology|June 27, 2022
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)Timothy M E Davis, Anna Giczewska, Yuliya Lokhnygina, et al.
Scientific Reports|October 16, 2020
A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over timeHulda Hrund Bjornsdottir, Araz Rawshani, Aidin Rawshani, et al.
JACC. Asia|August 22, 2025
Forecasting Atherosclerotic Cardiovascular Disease in South Asia Until 2040: A Bayesian Modeling ApproachAntoinette Cotton, Pedro Rvo Salerno, Zhuo Chen, et al.
Diabetes & Metabolic Syndrome|January 14, 2022
Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trialMatthew M Y Lee, Søren L Kristensen, Hertzel C Gerstein, et al.
The Lancet. Diabetes & Endocrinology|December 2, 2022
Treating chronic diseases without tackling excess adiposity promotes multimorbidityNaveed Sattar, John J V McMurray, Iain B McInnes, et al.
Cardiovascular Diabetology|August 24, 2025
Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes: an EXSCEL post hoc analysisRuth L Coleman, Amanda I Adler, Robert J Mentz, et al.
Thrombosis and Haemostasis|June 5, 2003
Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated by thrombin in human monocytes and THP-1 cells in vitro and in pregnant subjects in vivoPeter Clark, Fiona Jordan, Charles Pearson, et al.
European Journal of Nutrition|July 5, 2024
Low thiamine status in adults following low-carbohydrate / ketogenic diets: a cross-sectional comparative study of micronutrient intake and statusChaitong Churuangsuk, Anthony Catchpole, Dinesh Talwar, et al.
Endocrinology, Diabetes & Metabolism|March 17, 2022
Managing weight and glycaemic targets in people with type 2 diabetes-How far have we come?Matthias Blüher, Antonio Ceriello, Melanie Davies, et al.
Journal of the American College of Cardiology|June 17, 2017
Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 DiabetesJames L Januzzi, Javed Butler, Petr Jarolim, et al.
Pageof 129